The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Contribution of a Thickened Cell Wall and Its Glutamine Nonamidated Component to the Vancomycin Resistance Expressed by Staphylococcus aureus Mu50
Open accessAbstract
Staphylococcus aureus Mu50, which has reduced susceptibility to vancomycin, has a remarkably thickened cell wall with an increased proportion of glutamine nonamidated muropeptides. In addition, Mu50 had enhanced glutamine synthetase and l -glutamine d -fructose-6-phosphate aminotransferase activities, which are involved in the cell-wall peptidoglycan synthesis pathway. Furthermore, significantly increased levels of incorporation of 14 C-labeled d -glucose into the cell wall was observed in Mu50. Unlike a femC mutant S. aureus strain, increased levels of production of nonamidated muropeptides in Mu50 was not caused by lower levels of glutamine synthetase activity but was considered to be due to the glutamine depletion caused by increased glucose utilization by the cell to biosynthesize increased amounts of peptidoglycan. After the cells were allowed to synthesize cell wall in the absence or presence of glucose and glutamine, cells with different cell-wall thicknesses and with cell walls with different levels of cross-linking were prepared, and susceptibility testing of these cells demonstrated a strong correlation between the cell-wall thickness and the degree of vancomycin resistance. Affinity trapping of vancomycin molecules by the cell wall and clogging of the outer layers of peptidoglycan by bound vancomycin molecules were considered to be the mechanism of vancomycin resistance of Mu50. The reduced cross-linking and the increased affinity of binding to vancomycin of the Mu50 cell wall presumably caused by the increased proportion of nonamidated muropeptides may also contribute to the resistance to some extent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improved tools for biological sequence comparison.
Pearson, W. R., & Lipman, D. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.8.2444 · Cited by 11,227
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
Hiramatsu, K. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.1.135 · Cited by 1,984
Self-citationHiramatsu, K., Aritaka, N., Hanaki, H., Kawasaki, S., Hosoda, Y., Hori, S., Fukuchi, Y., & Kobayashi, I. (1997) · The Lancet · doi:10.1016/s0140-6736(97)07324-8 · Cited by 1,333
Self-citationPhysiology of the bacterial cell : a molecular approach
Neidhardt, F. C., Ingraham, J. L., & Schaechter, M. (1990) · Cited by 808
Tenover, F. C., Lancaster, M. V., Hill, B. C., Steward, C. D., Stocker, S. A., Hancock, G. A., O’Hara, C. M., Clark, N. C., & Hiramatsu, K. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.4.1020-1027.1998 · Cited by 376
Self-citationHanaki, H. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.2.199 · Cited by 366
Self-citationTenover, F. C., Lancaster, M. V., Hill, B. C., Steward, C. D., Stocker, S. A., Hancock, G. A., O’Hara, C. M., McAllister, S. K., Clark, N. C., & Hiramatsu, K. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.7.2167-2167.1998 · Cited by 362
Self-citationGhosh, S., Blumenthal, H. J., Davidson, E., & Roseman, S. (1960) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)69397-4 · Cited by 294
Sieradzki, K., & Tomasz, A. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.8.2557-2566.1997 · Cited by 274
Biosynthesis of the peptidoglycan of bacterial cell walls
Anderson, J. S., Meadow, P. M., Haskin, M. A., & Strominger, J. L. (1966) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(66)90056-7 · Cited by 264
Vancomycin resistance in staphylococci
Hiramatsu, K. (1998) · Drug Resistance Updates · doi:10.1016/s1368-7646(98)80029-0 · Cited by 227
Self-citationThe emergence of Staphylococcus aureus with reduced susceptibility to vancomycin in Japan
Hiramatsu, K. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00149-1 · Cited by 191
Self-citationKuroda, M., Kuwahara-Arai, K., & Hiramatsu, K. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2277 · Cited by 190
Self-citationHanaki, H., Labischinski, H., Inaba, Y., Kondo, N., Murakami, H., & Hiramatsu, K. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.3.315 · Cited by 173
Self-citationPLUMBRIDGE, J. A. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00067.x · Cited by 116
Gustafson, J. E., Strässle, A., Hächler, H., Kayser, F. H., & Berger‐Bächi, B. (1994) · Journal of Bacteriology · doi:10.1128/jb.176.5.1460-1467.1994 · Cited by 111
Pathway Choice in Glutamate Synthesis in Escherichia coli
Helling, R. B. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.17.4571-4575.1998 · Cited by 103
Fisher, S. H., & Sonenshein, A. L. (1984) · Journal of Bacteriology · doi:10.1128/jb.157.2.612-621.1984 · Cited by 72
Biosynthesis of the Peptidoglycan of Bacterial Cell Walls
Siewert, G., & Strominger, J. L. (1968) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)81734-9 · Cited by 62
Genetic basis for molecular epidemiology of MRSA
Hiramatsu, K., Kondo, N., & Ito, T. (1996) · Journal of Infection and Chemotherapy · doi:10.1007/bf02351563 · Cited by 60
Self-citationPhysiology of the Bacterial Cell. A Molecular Approach
Smith, C. A. (1992) · Biochemical Education · doi:10.1016/0307-4412(92)90139-d · Cited by 58
Reynolds, P. E., & Somner, E. A. (1990) · PubMed · Cited by 56
Aeschlimann, J. R., Hershberger, E., & Rybak, M. J. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.8.1914 · Cited by 53
Glutamine Synthetase and Heteroresistance in Methicillin-Resistant Staphylococcus aureus
Stranden, A., Roos, M. A., & Berger‐Bächi, B. (1996) · Microbial Drug Resistance · doi:10.1089/mdr.1996.2.201 · Cited by 46
Ornelas-Soares, A., de LENCASTRE, H., DeJonge, B. L. M., Gage, D. A., Chang, Y. S., & Tomasz, A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74310-5 · Cited by 43
Ghuysen, J., Nakel, M., & Kandler, O. (1971) · Biochemistry · doi:10.1021/bi00787a033 · Cited by 42
Linnett, P. E., & Strominger, J. L. (1974) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)42757-9 · Cited by 31
Genetic Basis for Molecular Epidemiology of MRSA.
Kondo, N., Ito, T., & Hiramatsu, K. (1997) · Nippon Saikingaku Zasshi · doi:10.3412/jsb.52.417 · Cited by 29
Self-citation
Cited by
Mechanisms of Antimicrobial Resistance in Bacteria
Tenover, F. C. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.03.011 · Cited by 1,682
Howden, B. P., Davies, J. K., Johnson, P. D. R., Stinear, T. P., & Grayson, M. L. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-09 · Cited by 962
Genetic Analysis of a High-Level Vancomycin-Resistant Isolate of Staphylococcus aureus
Weigel, L. M., Clewell, D. B., Gill, S. R., Clark, N. C., McDougal, L. K., Flannagan, S. E., Kolonay, J. F., Shetty, J., Killgore, G. E., & Tenover, F. C. (2003) · Science · doi:10.1126/science.1090956 · Cited by 889
The emergence and evolution of methicillin-resistant Staphylococcus aureus
Hiramatsu, K., Cui, L., Kuroda, M., & Ito, T. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(01)02175-8 · Cited by 825
Self-citationVancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance
Hiramatsu, K. (2001) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00091-3 · Cited by 759
Self-citation
Metadata
- Authors
- Cui, L., Murakami, H., Kuwahara-Arai, K., Hanaki, H., & Hiramatsu, K.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2000-09
- Volume
- 44
- Issue
- 9
- Pages
- 2276-2285
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2098499925
- Cited by
- 318
- References
- 28
- FWCI
- 10.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.